New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
June 6, 2014
06:43 EDTHUMHumana upgraded at Stifel
As previously reported, Stifel upgraded Humana to Buy from Hold. The firm upgraded shares based on improved reimbursement rate visibility, continued growth in the Medicare population, and a history of proven results and an attractive story. Price target is $155.
News For HUM From The Last 14 Days
Check below for free stories on HUM the last two weeks.
Sign up for a free trial to see the rest of the stories you've been missing.
September 12, 2014
12:04 EDTHUMHumana management to meet with Jefferies
Subscribe for More Information
September 10, 2014
08:42 EDTHUMHumana says all 2015 Medicare Advantage, PDP offerings approved
Subscribe for More Information
September 5, 2014
07:56 EDTHUMHumana likely to add new growth drivers, says Wells Fargo
Subscribe for More Information
September 4, 2014
12:49 EDTHUMJudges to revisit ObamaCare subsidies decision, The Hill reports
Subscribe for More Information
September 3, 2014
14:55 EDTHUMObamaCare business exchange to launch in 5 states next month, The Hill says
Subscribe for More Information
06:34 EDTHUMNext Obamacare enrollment period may be very difficult, NY Times says
Subscribe for More Information
September 2, 2014
08:34 EDTHUMHumana to reaffirm FY14 EPS view $7.25-$7.75, consensus $7.73
Members of Humana Inc.’s senior management team are scheduled to meet with investors at various times between September 3 and the end of the month. During such meetings, Humana’s management expects to reaffirm its guidance of $7.25-$7.75 in diluted EPS for the year ending December 31, 2014. This EPS guidance is consistent with that issued in Humana’s current report on Form 8-K filed with the U.S. SEC on July 30 and subsequently reiterated in investor presentations posted to the Investor Relations section of its web site.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use